Marc H.A. Jansen

1.8k total citations
42 papers, 921 citations indexed

About

Marc H.A. Jansen is a scholar working on Genetics, Hematology and Surgery. According to data from OpenAlex, Marc H.A. Jansen has authored 42 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 11 papers in Hematology and 9 papers in Surgery. Recurrent topics in Marc H.A. Jansen's work include Glioma Diagnosis and Treatment (14 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Marc H.A. Jansen is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Marc H.A. Jansen collaborates with scholars based in Netherlands, Israel and United States. Marc H.A. Jansen's co-authors include Gertjan J.L. Kaspers, Dannis G. van Vuurden, W. Peter Vandertop, Sophie E. M. Veldhuijzen van Zanten, David P. Noske, Esther Hulleman, Pieter Wesseling, Daniëlle J. Vugts, Esther Sánchez Aliaga and Laurine E. Wedekind and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Marc H.A. Jansen

40 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc H.A. Jansen Netherlands	18	497	261	224	178	134	42	921
Paolo Nozza Italy	21	512 1.0×	215 0.8×	337 1.5×	273 1.5×	187 1.4×	93	1.3k
Nathan Robison United States	16	572 1.2×	349 1.3×	270 1.2×	129 0.7×	122 0.9×	49	969
E. C. Quant United States	14	494 1.0×	261 1.0×	196 0.9×	226 1.3×	140 1.0×	25	871
René-Olivier Mirimanoff Switzerland	10	394 0.8×	192 0.7×	111 0.5×	327 1.8×	311 2.3×	15	899
Karin Dieckmann Austria	21	375 0.8×	233 0.9×	85 0.4×	373 2.1×	289 2.2×	51	1.0k
Christopher McPherson United States	20	335 0.7×	257 1.0×	319 1.4×	422 2.4×	199 1.5×	33	1.2k
Bożenna Dembowska–Bagińska Poland	17	239 0.5×	143 0.5×	448 2.0×	154 0.9×	218 1.6×	68	1.0k
David Barba United States	11	243 0.5×	232 0.9×	219 1.0×	194 1.1×	209 1.6×	16	903
Catherine McBain United Kingdom	22	419 0.8×	121 0.5×	244 1.1×	385 2.2×	360 2.7×	57	1.4k
Jonathan W. Rick United States	17	207 0.4×	129 0.5×	236 1.1×	114 0.6×	288 2.1×	50	1.1k

Countries citing papers authored by Marc H.A. Jansen

Since Specialization

Citations

This map shows the geographic impact of Marc H.A. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc H.A. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc H.A. Jansen more than expected).

Fields of papers citing papers by Marc H.A. Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc H.A. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc H.A. Jansen. The network helps show where Marc H.A. Jansen may publish in the future.

Co-authorship network of co-authors of Marc H.A. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Marc H.A. Jansen. A scholar is included among the top collaborators of Marc H.A. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc H.A. Jansen. Marc H.A. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nicolai, Rebecca, Silvia Rosina, Brigitte Bader‐Meunier, et al.. (2025). Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers. Lara D. Veeken. 64(8). 4732–4737. 1 indexed citations

Veldkamp, Saskia R, Wineke Armbrust, J. Merlijn van den Berg, et al.. (2025). Advances in JDM: biomarker and MRI sensitivity, outcomes and steroid management in a Dutch national prospective cohort. Lara D. Veeken. 64(11). 5622–5628.

Veldkamp, Saskia R, Mark de Groot, Saskia Haitjema, et al.. (2025). Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes. SHILAP Revista de lepidopterología. 7. 55–63. 1 indexed citations

Veldkamp, Saskia R, Femke van Wijk, Annet van Royen‐Kerkhof, & Marc H.A. Jansen. (2024). Personalised medicine in juvenile dermatomyositis: From novel insights in disease mechanisms to changes in clinical practice. Best Practice & Research Clinical Rheumatology. 38(3). 101976–101976. 3 indexed citations

Lindemans, Caroline A., et al.. (2024). Pharmacokinetics and Pharmacodynamics of Systemic Corticosteroids in Autoimmune and Inflammatory Diseases: A Review of Current Evidence. Clinical Pharmacokinetics. 63(9). 1251–1270. 3 indexed citations

Veldkamp, Saskia R, Johan Lim, Annet van Royen‐Kerkhof, et al.. (2024). Type I interferon biomarker in idiopathic inflammatory myopathies: associations of Siglec-1 with disease activity and treatment response. Lara D. Veeken. 64(5). 2979–2986. 4 indexed citations

Černelič-Bizjak, Maša, et al.. (2023). Vaccinology in pediatric rheumatology: Past, present and future. Frontiers in Pediatrics. 10. 1098332–1098332. 2 indexed citations

Roock, Sytze de, et al.. (2023). Safety of Measles-Mumps-Rubella booster vaccination in patients with juvenile idiopathic arthritis: A long-term follow-up study. Vaccine. 41(18). 2976–2981. 2 indexed citations

Jansen, Marc H.A., Christien Rondaan, G. Elizabeth Legger, et al.. (2022). EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Annals of the Rheumatic Diseases. 82(1). 35–47. 38 indexed citations

10.

Lerkvaleekul, Butsabong, Saskia R Veldkamp, Marlot van der Wal, et al.. (2021). Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response. Lara D. Veeken. 61(5). 2144–2155. 31 indexed citations

11.

Haar, Nienke M. ter, Marc H.A. Jansen, Joost Frenkel, & Sebastiaan J. Vastert. (2020). How autoinflammation may turn into autoimmune inflammation: Insights from monogenetic and complex IL-1 mediated auto-inflammatory diseases. Clinical Immunology. 219. 108538–108538. 7 indexed citations

12.

Alizai, Patrick H., et al.. (2017). Impact of obesity on postoperative complications after laparoscopic and open incisional hernia repair – A prospective cohort study. International Journal of Surgery. 48. 220–224. 15 indexed citations

13.

Zanten, Sophie E. M. Veldhuijzen van, Adam Lane, Martijn W. Heymans, et al.. (2017). External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry. Journal of Neuro-Oncology. 134(1). 231–240. 19 indexed citations

14.

Jansen, Marc H.A., Tonny Lagerweij, A. Sewing, et al.. (2016). Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models. Molecular Cancer Therapeutics. 15(9). 2166–2174. 50 indexed citations

15.

Jansen, Marc H.A., Sophie E. M. Veldhuijzen van Zanten, Dannis G. van Vuurden, et al.. (2016). Molecular Drug Imaging: ⁸⁹Zr-Bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma. Journal of Nuclear Medicine. 58(5). 711–716. 72 indexed citations

16.

Zanten, Sophie E. M. Veldhuijzen van, Marc H.A. Jansen, Jos W. R. Twisk, et al.. (2015). Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey. Neuro-Oncology. 18(4). 582–588. 19 indexed citations

17.

Zanten, Sophie E. M. Veldhuijzen van, Marc H.A. Jansen, Esther Sánchez Aliaga, et al.. (2014). A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands. Expert Review of Anticancer Therapy. 15(2). 157–164. 38 indexed citations

18.

Vuurden, Dannis G. van, Marc H.A. Jansen, Laurine E. Wedekind, et al.. (2013). In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine Glioma. PLoS ONE. 8(4). e61512–e61512. 106 indexed citations

19.

Jansen, Marc H.A., Dannis G. van Vuurden, W. Peter Vandertop, & Gertjan J.L. Kaspers. (2011). Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology. Cancer Treatment Reviews. 38(1). 27–35. 151 indexed citations

20.

Klink, Christian, S. Willis, Uwe Neumann, & Marc H.A. Jansen. (2010). Protektives Ileostoma vs. protektives Transversostoma. Der Chirurg. 81(11). 974–977. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact